Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Procter & Gamble (PG)

Procter & Gamble Q2 core EPS flat at $1.88; organic sales flat; FY26 core EPS guidance maintained

Mixed Impact 3 of 5 earnings Written later

Procter & Gamble reported flat organic sales and flat core earnings per share for the quarter ended December 31, 2025, while diluted EPS fell to $1.78 from $1.88 after a $0.10 restructuring charge. The company maintained its fiscal 2026 organic sales, net sales and core EPS growth guidance, which matters to shareholders because it signals no change to the full-year outlook despite soft quarterly volume.

Key points

  • Organic sales growth was 0%, with organic volume down 1% and pricing up 1%.
  • Core EPS was $1.88, flat year over year; currency-neutral core EPS was $1.85, down 2%.
  • Diluted EPS was $1.78 versus $1.88 a year earlier, including $0.10 of incremental restructuring.
  • FY 2026 guidance: organic sales growth 0% to +4%, core EPS growth 0% to +4%, and all-in EPS growth 1% to 6%.

The filing

CompanyProcter & Gamble (PG)
Form8-K, current report
Filed with the SECJan 22, 2026, 11:53 AM ET
Accession number0000080424-26-000009

Items reported: 7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 2:16 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on January 22, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.